We read with great interest the recent article by Wetzstein et al. that reported the
overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy.
1
Nontuberculous mycobacteria (NTM), especially from pulmonary specimen, have been
reported increasing globally.
2
The geographical distribution of NTM cases varies significantly
3
and the epidemiology is relatively poorly understood in comparison to the genetically
related Mycobacterium tuberculosis. NTM is also not notifiable and routinely monitored in most settings. For many countries,
microbiological data is not even publicly available.
2
For some regions and continents, the epidemiology has been reviewed, but to our knowledge,
no study has summarized the distribution of species among patients with NTM pulmonary
disease (NTM-PD) in Europe. Therefore, we performed a systematic review of PubMed/MEDLINE,
Embase, Scopus, and Web of Science, on July 10, 2022 to identify studies with species
distribution data among patients with NTM-PD, the most common manifestation, in Europe
(as defined by the WHO regions https://www.who.int/countries). Only studies with data on NTM-PD were eligible for inclusion, regardless of whether
guideline criteria were used, while studies without clinical data (i.e., only microbiology)
were excluded. Among others, we extracted the number of patients fulfilling diagnostic
guideline criteria.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of InfectionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: systematic review and individual patient data meta-analysis.J Infect. 2022; 84: 8-16
- Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.Int J Infect Dis. 2022;
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.Eur Respir J. 2013; 42: 1604-1613
- Nontuberculous mycobacteria under scrutiny in the Geneva area (2015–2020).Respiration. 2022; 101: 367-375
- Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.BMC Infect Dis. 2019; 19: 1061
- Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands.Thorax. 2009; 64: 502-506
- Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country.ERJ Open Res. 2019; 5
- Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.Epidemiol Infect. 2017; 145: 515-522
- Clinical and radiological features of Mycobacterium kansasii and other NTM infections.Respir Med. 2012; 106: 1472-1477
- Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece – relation to microbiological data.Future Microbiol. 2015; 10: 1301-1306
- Nontuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000.Respir Med. 2003; 97: 257-263
- Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis.Eur J Clin Microbiol Infect Dis. 2009; 28: 739-744
- Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.Future Microbiol. 2011; 6: 1099-1109
- Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece.Int J Tube Lung Dis. 2008; 12: 807-812
- Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.Scand J Infect Dis. 2012; 44: 815-819
- Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients.Eur Respir J. 2006; 28: 1211-1215
- Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?.New Microbiol. 2010; 33: 399-403
- Non-tuberculous mycobacteria infection: 75 cases.Tube Toraks. 2012; 60: 20-31
- Non-tuberculous mycobacteria in HIV-negative patients with pulmonary disease in Lisbon, Portugal.Scand J Infect Dis. 2010; 42: 626-628
- Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994–2015.Eur J Clin Microbiol Infect Dis. 2017; 36: 1425-1432
- Clinical features of infection caused by non-tuberculous mycobacteria: 7 years' experience.Infection. 2018; 46: 357-363
- Geographic distribution of Nontuberculous mycobacteria isolated from clinical specimens: a systematic review.Semin Respir Crit Care Med. 2018; 39: 336-342
- The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature.Int J Tube Lung Dis. 2008; 12: 987-993
- Clinical relevance of Mycobacterium malmoense isolation in The Netherlands.Eur Respir J. 2009; 34: 926-931
Article info
Publication history
Published online: March 11, 2023
Accepted:
March 9,
2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
